Astera Labs (NASDAQ:ALAB) Shares Gap Up - Still a Buy?
Astera Labs (NASDAQ:ALAB) shares opened at $181.50 after closing at $169.55, reaching $191.34 with a trading volume of 1,811,128. Analysts have mixed ratings, with Barclays at "equal weight" and a $155 target, while Morgan Stanley raised theirs to $200. The company reported $0.44 EPS, exceeding estimates, with revenue up 149.5% year-over-year. Insider sales totaled over $192 million in three months, and institutional investors have recently increased their stakes. The average target price is $162.06, with a consensus rating of "Moderate Buy."
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $169.55, but opened at $181.50. Astera Labs shares last traded at $191.3410, with a volume of 1,811,128 shares changing hands.
Analysts Set New Price Targets
- Are These 3 Beaten-Down Stocks Ready to Rebound?
Several brokerages recently issued reports on ALAB. Barclays restated an "equal weight" rating and issued a $155.00 price objective on shares of Astera Labs in a report on Monday, October 20th. Morgan Stanley boosted their price objective on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, August 29th. Bank of America assumed coverage on Astera Labs in a research report on Friday, October 3rd. They set a "neutral" rating and a $230.00 price objective for the company. Zacks Research downgraded Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Finally, Evercore ISI boosted their price objective on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $162.06.
View Our Latest Analysis on ALAB
Astera Labs Price Performance
- 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think
The company has a 50 day moving average price of $196.28 and a 200 day moving average price of $134.96. The firm has a market cap of $33.36 billion, a PE ratio of 355.71, a PEG ratio of 4.33 and a beta of 1.43.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same quarter in the prior year, the business earned $0.13 earnings per share. The company's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Insider Transactions at Astera Labs
- MarketBeat Week in Review – 06/23 - 6/27
In other Astera Labs news, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the completion of the transaction, the chief financial officer owned 518,996 shares in the company, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the transaction, the director owned 99,154 shares of the company's stock, valued at $17,195,286.68. The trade was a 20.14% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,092,997 shares of company stock valued at $192,231,120 in the last three months. Insiders own 12.50% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Oliver Lagore Vanvalin Investment Group acquired a new stake in Astera Labs in the second quarter valued at $29,000. Bernard Wealth Management Corp. acquired a new stake in Astera Labs in the second quarter valued at $36,000. Clearstead Trust LLC boosted its stake in shares of Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company's stock valued at $42,000 after acquiring an additional 461 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock valued at $43,000 after acquiring an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its stake in shares of Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock valued at $44,000 after acquiring an additional 283 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.
Astera Labs Company Profile
(Get Free Report)Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- How to Invest in Small Cap Stocks
- Comfort Systems Is the AI Data Center Stock Beating NVDA, AVGO, & AMD
- 3 Monster Growth Stocks to Buy Now
- Cameco's $80 Billion U.S. Nuclear Deal Changes Everything
- Using the MarketBeat Stock Split Calculator
- NU Stock: U.S. Bank License May Be the Next Growth Catalyst
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Astera Labs Right Now?
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
